Q4 EPS Estimate for Option Care Health Decreased by Analyst

Option Care Health, Inc. (NASDAQ:OPCH) – Analysts at William Blair dropped their Q4 2024 earnings estimates for Option Care Health in a report released on Thursday, October 31st. William Blair analyst M. Larew now anticipates that the company will earn $0.30 per share for the quarter, down from their prior forecast of $0.35. The consensus estimate for Option Care Health’s current full-year earnings is $1.22 per share. William Blair also issued estimates for Option Care Health’s Q1 2025 earnings at $0.24 EPS, Q2 2025 earnings at $0.30 EPS and Q3 2025 earnings at $0.35 EPS.

A number of other analysts have also weighed in on the stock. Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the company from $38.00 to $26.00 in a research report on Thursday. Barrington Research dropped their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday. JMP Securities raised their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Finally, Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $43.00 to $29.00 in a research report on Wednesday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $31.60.

Option Care Health Stock Up 4.6 %

NASDAQ:OPCH opened at $24.11 on Friday. The firm has a market capitalization of $4.12 billion, a P/E ratio of 20.26, a PEG ratio of 1.79 and a beta of 1.29. Option Care Health has a 1-year low of $22.84 and a 1-year high of $34.63. The company’s fifty day moving average price is $30.49 and its 200-day moving average price is $29.92. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.36.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.22 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%.

Hedge Funds Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently modified their holdings of the business. Blue Trust Inc. lifted its stake in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after buying an additional 377 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares in the last quarter. Trust Point Inc. lifted its stake in shares of Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after buying an additional 622 shares in the last quarter. Nisa Investment Advisors LLC increased its position in Option Care Health by 5.4% during the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after purchasing an additional 690 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its position in Option Care Health by 3.8% during the third quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock worth $621,000 after purchasing an additional 735 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.